Pegylated Interferon Alpha-1A Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 120 mcg, 150 mcg, 180 mcg
Reference Brands: Pegasys® (US & EU), PegIntron® (EU)
Category:
Hepatitis
PegIntron® is a pegylated interferon alpha-2b injection used to treat chronic Hepatitis C. Available in 120, 150, and 180 mcg prefilled syringes, it’s given once weekly at 1.5 mcg/kg subcutaneously. Often combined with ribavirin, PegIntron® is manufactured to EU-GMP and USFDA standards, making it suitable for B2B supply, hospital tenders, and licensing in EU and US markets.
Pegylated Interferon Alpha-1a is available in Injection
and strengths such as 120 mcg, 150 mcg, 180 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pegylated Interferon Alpha-1a is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pegylated Interferon Alpha-1a can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
PegIntron® is a pegylated interferon alpha-2b injection used for treating chronic Hepatitis C infection. It delivers a sustained antiviral effect by stimulating the immune response against the virus. Available in prefilled syringes with strengths of 120 mcg, 150 mcg, and 180 mcg, PegIntron® is administered once weekly via subcutaneous injection, typically dosed at 1.5 mcg/kg. Often combined with ribavirin, it is manufactured under EU-GMP and USFDA standards. PegIntron® is widely used in hospital tenders, B2B supply, and licensing with comprehensive regulatory dossiers to support market entry in EU and US.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing